Colgate director granted shares and stock options

Q: How many Colgate-Palmolive (CL) shares did Kimberly A. Nelson receive in the stock grant?

She received 2,075 shares of Common Stock. This annual director stock grant was credited under Colgate-Palmolive’s incentive compensation plan and brought her directly held Common Stock position to 11,634 shares following the transaction.

Q: When do Kimberly A. Nelson’s new Colgate-Palmolive (CL) options become exercisable?

The options vest in three equal annual installments. According to the filing, they become exercisable in equal annual installments over three years, beginning on the first anniversary of the May 11, 2026 grant date, and expire on May 11, 2034.

COLGATE PALMOLIVE CO director Kimberly A. Nelson received new equity compensation awards.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

COLGATE PALMOLIVE CO director Kimberly A. Nelson received new equity compensation awards. On May 11, 2026, she acquired 2,075 shares of Common Stock as an annual director stock grant under the issuer's incentive compensation plan, increasing her direct holdings to 11,634 shares.

On the same date, she also received a stock option for 2,424 shares of Common Stock with an exercise price of $86.74 per share, expiring on May 11, 2034. This option becomes exercisable in equal annual installments over three years, beginning on the first anniversary of the grant date. The filing also lists additional indirect holdings through a trust, spouse, and a family trust.

Insider Trade Summary

Grant/Award: 4,499 shares

Grant/Award 5 txns

Insider Nelson Kimberly A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	2,424	$0.00	$0.00
Grant/Award	Common Stock	2,075	$0.00	$0.00
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 2,424 contracts (Direct); Common Stock — 11,634 shares (Direct); Common Stock — 575 shares (Indirect, By Family Trust); Common Stock — 215 shares (Indirect, By Spouse); Common Stock — 1,799 shares (Indirect, By Trust)

Footnotes (3)

F1. Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan.
F2. Annual director stock option grant under the issuer's incentive compensation plan.
F3. Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.

Key Figures

Director stock grant: 2,075 shares Direct holdings after grant: 11,634 shares Stock option size: 2,424 options +3 more

6 metrics

Director stock grant 2,075 shares Annual director stock grant of Common Stock on May 11, 2026

Direct holdings after grant 11,634 shares Common Stock directly owned after the 2,075-share grant

Stock option size 2,424 options Stock Option (Right to Buy) for underlying Common Stock

Option exercise price $86.74 per share Conversion or exercise price of the stock option

Option expiration May 11, 2034 Expiration date of the 2,424-share stock option grant

Indirect trust holdings 1,799 shares Common Stock held indirectly by trust after the reported date

Key Terms

Annual director stock grant, incentive compensation plan, stock unit account, Stock Option (Right to Buy), +1 more

5 terms

Annual director stock grant financial

"Annual director stock grant under the issuer's incentive compensation plan"

incentive compensation plan financial

"under the issuer's incentive compensation plan, credited to a stock unit account"

An incentive compensation plan is a formal program that rewards employees and executives with bonuses, stock, or other payments tied to specific performance goals—such as revenue, profit, productivity, or long‑term share price. Investors watch these plans because they shape how leaders make decisions and take risks; like paying a coach by wins rather than effort, well‑designed plans can drive sustainable growth while poor designs can encourage short‑term behaviors that harm shareholder value.

stock unit account financial

"credited to a stock unit account pursuant to the issuer's incentive compensation plan"

Stock Option (Right to Buy) financial

"Stock Option (Right to Buy)"

exercisable in equal annual installments financial

"Option becomes exercisable in equal annual installments over three years"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Kimberly A. Nelson report in this Colgate-Palmolive (CL) Form 4?

Kimberly A. Nelson reported new equity awards from Colgate-Palmolive. She received 2,075 shares of Common Stock as an annual director stock grant and a stock option for 2,424 shares, both granted under the company’s incentive compensation plan.

How many Colgate-Palmolive (CL) shares did Kimberly A. Nelson receive in the stock grant?

She received 2,075 shares of Common Stock. This annual director stock grant was credited under Colgate-Palmolive’s incentive compensation plan and brought her directly held Common Stock position to 11,634 shares following the transaction.

What are the key terms of Kimberly A. Nelson’s new Colgate-Palmolive (CL) stock option?

The new option covers 2,424 shares at an exercise price of $86.74. It is a right to buy Common Stock, expires on May 11, 2034, and becomes exercisable in equal annual installments over three years starting on the first anniversary of the grant date.

How many Colgate-Palmolive (CL) shares does Kimberly A. Nelson hold after these awards?

She holds 11,634 shares of Common Stock directly after the grant. The Form 4 also lists indirect holdings of 1,799 shares by a trust, 215 shares by her spouse, and 575 shares by a family trust, all reported as indirect ownership.

Are Kimberly A. Nelson’s Colgate-Palmolive (CL) Form 4 transactions open-market buys or compensation awards?

The reported transactions are compensation-related awards, not open-market purchases. The filing classifies them as grants or awards under Colgate-Palmolive’s incentive compensation plan, including an annual director stock grant and an annual director stock option grant.

When do Kimberly A. Nelson’s new Colgate-Palmolive (CL) options become exercisable?

The options vest in three equal annual installments. According to the filing, they become exercisable in equal annual installments over three years, beginning on the first anniversary of the May 11, 2026 grant date, and expire on May 11, 2034.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 05/13/2026 - 04:46 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nelson Kimberly A

(Last)

(First)

(Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK

10022

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/11/2026		A⁽¹⁾		2,075	A	$0.0000	11,634	D
Common Stock								575	I	By Family Trust
Common Stock								215	I	By Spouse
Common Stock								1,799	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$86.74	05/11/2026		A⁽²⁾		2,424		⁽³⁾	05/11/2034	Common Stock	2,424	$0.0000	2,424	D

Explanation of Responses:

1. Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan.

2. Annual director stock option grant under the issuer's incentive compensation plan.

3. Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.

	/s/ Kristine Hutchinson, Attorney-in-Fact	05/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR